These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25550127)

  • 1. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
    Posadas-Sánchez R; López-Uribe ÁR; Posadas-Romero C; Pérez-Hernández N; Rodríguez-Pérez JM; Ocampo-Arcos WA; Fragoso JM; Cardoso-Saldaña G; Vargas-Alarcón G
    Immunobiology; 2017 Oct; 222(10):960-966. PubMed ID: 27615511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat intake influences the effect of the hepatic lipase C-514T polymorphism on HDL-cholesterol levels in children.
    Riestra P; López-Simón L; Ortega H; Gorgojo L; Martin-Moreno JM; Schoppen S; de Oya M; Garcés C
    Exp Biol Med (Maywood); 2009 Jul; 234(7):744-9. PubMed ID: 19429860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -514C>T polymorphism in the LIPC gene modifies type 2 diabetes risk through modulation of HDL-cholesterol levels in Mexicans.
    Guerra-García MT; Moreno-Macías H; Ochoa-Guzmán A; Ordoñez-Sánchez ML; Rodríguez-Guillen R; Vázquez-Cárdenas P; Ortíz-Ortega VM; Peimbert-Torres M; Aguilar-Salinas CA; Tusié-Luna MT
    J Endocrinol Invest; 2021 Mar; 44(3):557-565. PubMed ID: 32617858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.
    Ordovas JM; Corella D; Demissie S; Cupples LA; Couture P; Coltell O; Wilson PW; Schaefer EJ; Tucker KL
    Circulation; 2002 Oct; 106(18):2315-21. PubMed ID: 12403660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.
    Hokanson JE; Cheng S; Snell-Bergeon JK; Fijal BA; Grow MA; Hung C; Erlich HA; Ehrlich J; Eckel RH; Rewers M
    Diabetes; 2002 Apr; 51(4):1208-13. PubMed ID: 11916946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study.
    Couture P; Otvos JD; Cupples LA; Lahoz C; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):815-22. PubMed ID: 10712408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The association study of the LIPC -250g/A polymorphism and high-carbohydrate/low-fat diet induced serum lipid and apolipoprotein concentration changes in healthy youth].
    Hu MS; Li ZK; Fang DZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):727-30, 735. PubMed ID: 24325099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis.
    Soyal SM; Sandhofer A; Hahne P; Oberkofler H; Felder T; Iglseder B; Miller K; Krempler F; Patsch JR; Paulweber B; Patsch W
    Atherosclerosis; 2011 Jun; 216(2):374-80. PubMed ID: 21371711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hepatic lipase -514T allele with coronary artery disease and ankle-brachial index, dependence on the lipoprotein phenotype: the GENES study.
    Verdier C; Ruidavets JB; Bongard V; Taraszkiewicz D; Martinez LO; Elbaz M; Ferrières J; Perret B
    PLoS One; 2013; 8(7):e67805. PubMed ID: 23874450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men.
    Zhang C; Lopez-Ridaura R; Rimm EB; Rifai N; Hunter DJ; Hu FB
    Am J Clin Nutr; 2005 Jun; 81(6):1429-35. PubMed ID: 15941898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
    Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.
    Miljkovic-Gacic I; Bunker CH; Ferrell RE; Kammerer CM; Evans RW; Patrick AL; Kuller LH
    Metabolism; 2006 Jan; 55(1):96-102. PubMed ID: 16324926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
    Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
    Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lipase gene -514C/T polymorphism in the Guangxi Hei Yi Zhuang and Han populations.
    Wu J; Yin R; Lin W; Pan S; Yang D
    Lipids; 2008 Aug; 43(8):733-40. PubMed ID: 18592285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.